SIMILAR PATTERNS OF AMINO ACIDS FOR 3G4L_B_ROFB902
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m2p | CASEIN KINASE II,ALPHA CHAIN (Zea mays) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHNA A 351 (-3.8A)HNA A 351 ( 3.8A)HNA A 351 (-3.6A) | 1.42A | 3g4lB-1m2pA:undetectable | 3g4lB-1m2pA:22.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.48A | 3g4lB-1sojA:41.7 | 3g4lB-1sojA:32.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sxj | ACTIVATOR 1 41 KDASUBUNIT (Saccharomycescerevisiae) |
PF00004(AAA)PF08542(Rep_fac_C) | 5 | MET D 61LEU D 58PRO D 132ILE D 92MET D 88 | None | 1.38A | 3g4lB-1sxjD:undetectable | 3g4lB-1sxjD:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wkp | FLOWERING LOCUS TPROTEIN (Arabidopsisthaliana) |
PF01161(PBP) | 5 | TYR A 151LEU A 89PRO A 136ILE A 150PHE A 142 | None | 1.37A | 3g4lB-1wkpA:undetectable | 3g4lB-1wkpA:18.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 211HIS A 212ASP A 362PRO A 366TRP A 376PHE A 416 | IBM A 503 (-4.6A)None ZN A 501 (-2.5A)NoneNoneIBM A 503 (-3.4A) | 0.44A | 3g4lB-1zklA:45.4 | 3g4lB-1zklA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oze | ORF DELTA' (Streptococcuspyogenes) |
PF13614(AAA_31) | 5 | ASP A 156LEU A 66ILE A 159MET A 181PHE A 283 | None | 1.36A | 3g4lB-2ozeA:undetectable | 3g4lB-2ozeA:23.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372MET A 485ASP A 530LEU A 531PRO A 534TRP A 544THR A 545ILE A 548MET A 549MET A 569PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)None ZN A 1 (-2.5A)NoneNoneNoneNPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 ( 4.7A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 0.41A | 3g4lB-2qykA:52.0 | 3g4lB-2qykA:85.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 281HIS A 282MET A 395ASP A 440LEU A 441PRO A 444TRP A 454THR A 455ILE A 458PHE A 494 | NoneNoneNone ZN A 1 (-2.5A)NoneNoneNoneNoneNoneNone | 0.55A | 3g4lB-2qymA:43.1 | 3g4lB-2qymA:83.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 281PRO A 444TRP A 454THR A 455MET A 459 | None | 0.96A | 3g4lB-2qymA:43.1 | 3g4lB-2qymA:83.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 5 | TYR A 680HIS A 681MET A 797ASP A 835THR A 854 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)None ZN A 1 (-2.6A)None | 1.27A | 3g4lB-2r8qA:38.9 | 3g4lB-2r8qA:29.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 6 | TYR A 680HIS A 681MET A 797ASP A 835TRP A 849PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)None ZN A 1 (-2.6A)NoneIBM A 3 (-3.6A) | 0.41A | 3g4lB-2r8qA:38.9 | 3g4lB-2r8qA:29.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a98 | DEDICATOR OFCYTOKINESIS PROTEIN2 (Homo sapiens) |
PF07653(SH3_2)PF16172(DOCK_N) | 5 | ASP A 162LEU A 163THR A 149ILE A 152MET A 120 | None | 1.47A | 3g4lB-3a98A:undetectable | 3g4lB-3a98A:17.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 612HIS A 613ASP A 764LEU A 765PHE A 820 | VDN A 1 (-4.8A)VDN A 1 (-4.3A)NoneVDN A 1 ( 4.7A)VDN A 1 (-3.6A) | 0.61A | 3g4lB-3b2rA:31.6 | 3g4lB-3b2rA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 612HIS A 613ASP A 764LEU A 765PHE A 820 | None MG A 877 (-4.4A) ZN A 876 (-2.5A)WAN A 901 ( 4.7A)WAN A 901 (-3.7A) | 0.59A | 3g4lB-3bjcA:34.3 | 3g4lB-3bjcA:19.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 555HIS A 556MET A 670ASP A 726PRO A 730TRP A 740ILE A 744PHE A 781 | NoneNoneIBM A 3 (-4.5A) ZN A 1 (-2.6A)NoneNoneIBM A 3 (-4.3A)IBM A 3 (-3.5A) | 0.33A | 3g4lB-3ecnA:44.8 | 3g4lB-3ecnA:32.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 330MET A 439LEU A 485MET A 503PHE A 538 | ZN A 801 (-3.4A)D71 A 901 ( 4.0A)NoneD71 A 901 (-3.6A)D71 A 901 (-3.9A) | 1.24A | 3g4lB-3g4gA:52.7 | 3g4lB-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 325HIS A 326ASP A 484LEU A 485PRO A 488TRP A 498THR A 499ILE A 502MET A 503MET A 523PHE A 538 | NoneD71 A 901 (-4.5A) ZN A 801 (-2.6A)NoneNoneNoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 ( 4.0A)D71 A 901 (-3.9A) | 0.58A | 3g4lB-3g4gA:52.7 | 3g4lB-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 325HIS A 326MET A 439ASP A 484LEU A 485PRO A 488TRP A 498THR A 499ILE A 502MET A 503PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 ( 4.0A) ZN A 801 (-2.6A)NoneNoneNoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-3.9A) | 0.59A | 3g4lB-3g4gA:52.7 | 3g4lB-3g4gA:74.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibj | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I)PF01590(GAF)PF13185(GAF_2) | 6 | TYR A 655HIS A 656ASP A 808LEU A 809ILE A 826PHE A 862 | NoneNone ZN A 1 (-2.7A)NoneNoneNone | 0.92A | 3g4lB-3ibjA:32.7 | 3g4lB-3ibjA:17.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jb9 | PRE-MRNA-SPLICINGFACTOR CWF11 (Schizosaccharomycespombe) |
PF13087(AAA_12)PF16399(Aquarius_N) | 5 | MET X 745LEU X1032THR X 990ILE X 989PHE X 642 | None | 1.41A | 3g4lB-3jb9X:undetectable | 3g4lB-3jb9X:14.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n3z | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252MET A 365ASP A 402TRP A 416PHE A 456 | NoneNone ZN A 507 (-2.9A)NoneIBM A 1 (-3.4A) | 0.60A | 3g4lB-3n3zA:41.0 | 3g4lB-3n3zA:30.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 233HIS A 234MET A 347ASP A 392LEU A 393PRO A 396TRP A 406THR A 407ILE A 410MET A 411MET A 431PHE A 446 | NoneNoneZG2 A 506 (-3.9A) ZN A 1 (-2.6A)NoneZG2 A 506 ( 4.5A)NoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)NoneZG2 A 506 (-3.4A)ZG2 A 506 (-3.6A) | 0.50A | 3g4lB-3o57A:51.5 | 3g4lB-3o57A:80.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pb9 | GLUTAMINYL-PEPTIDECYCLOTRANSFERASE-LIKE PROTEIN (Homo sapiens) |
PF04389(Peptidase_M28) | 5 | LEU X 368PRO X 276THR X 344ILE X 342PHE X 278 | None | 1.49A | 3g4lB-3pb9X:undetectable | 3g4lB-3pb9X:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qi3 | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252MET A 365ASP A 402TRP A 416PHE A 456 | PDB A 600 (-4.6A)PDB A 600 ( 4.7A) ZN A 534 (-2.7A)NonePDB A 600 (-3.5A) | 0.59A | 3g4lB-3qi3A:41.4 | 3g4lB-3qi3A:24.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TRP A 332THR A 333ILE A 336MET A 337MET A 357PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)MET A 357 (-0.0A)PHE A 372 (-1.3A) | 0.53A | 3g4lB-3sl5A:52.8 | 3g4lB-3sl5A:98.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 524HIS A 525ASP A 674LEU A 675ILE A 692PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A) ZN A 772 (-2.4A)C1L A 1 (-4.3A)C1L A 1 (-4.3A)C1L A 1 (-3.5A) | 0.83A | 3g4lB-3ui7A:38.2 | 3g4lB-3ui7A:27.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 7 | TYR A 367HIS A 368MET A 482ASP A 521TRP A 535ILE A 538PHE A 573 | WYQ A 701 (-4.5A)NoneWYQ A 701 (-4.5A) ZN A 702 (-1.9A)NoneWYQ A 701 ( 4.1A)WYQ A 701 (-3.4A) | 0.78A | 3g4lB-3v94A:39.8 | 3g4lB-3v94A:30.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 655HIS A 656ASP A 808LEU A 809ILE A 826PHE A 862 | NoneNone ZN A1001 (-2.5A)NoneNoneNone | 0.58A | 3g4lB-4htzA:38.6 | 3g4lB-4htzA:27.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 655LEU A 809ILE A 826MET A 847PHE A 862 | None | 0.99A | 3g4lB-4htzA:38.6 | 3g4lB-4htzA:27.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 5 | TYR A 668HIS A 669MET A 785ASP A 822THR A 841 | NoneNoneNone ZN A1001 (-2.5A)None | 1.38A | 3g4lB-4i15A:38.2 | 3g4lB-4i15A:32.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 6 | TYR A 668HIS A 669MET A 785ASP A 822TRP A 836PHE A 877 | NoneNoneNone ZN A1001 (-2.5A)NoneNone | 0.46A | 3g4lB-4i15A:38.2 | 3g4lB-4i15A:32.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jr7 | CASEIN KINASE IISUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00069(Pkinase) | 5 | HIS A 193LEU A 86ILE A 213MET A 202PHE A 152 | NoneNoneGNP A 401 (-4.6A)GNP A 401 (-3.6A)None | 1.43A | 3g4lB-4jr7A:undetectable | 3g4lB-4jr7A:24.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4md8 | CASEIN KINASE IISUBUNIT ALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | HIS E 154LEU E 85ILE E 174MET E 163PHE E 113 | None | 1.32A | 3g4lB-4md8E:undetectable | 3g4lB-4md8E:22.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406ASP A 564LEU A 565PRO A 568TRP A 578THR A 579ILE A 582MET A 583MET A 603PHE A 618 | None MG A 804 ( 4.9A) ZN A 801 (-2.5A)NoneNoneNoneNoneNoneNoneNoneNone | 0.73A | 3g4lB-4wziA:52.2 | 3g4lB-4wziA:47.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519ASP A 564LEU A 565PRO A 568TRP A 578THR A 579ILE A 582MET A 583PHE A 618 | None MG A 804 ( 4.9A)None ZN A 801 (-2.5A)NoneNoneNoneNoneNoneNoneNone | 0.58A | 3g4lB-4wziA:52.2 | 3g4lB-4wziA:47.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y9s | EPOXIDE HYDROLASE (Solanumtuberosum) |
PF00561(Abhydrolase_1) | 5 | HIS A 104ASP A 265LEU A 266THR A 182PHE A 189 | None | 1.41A | 3g4lB-4y9sA:undetectable | 3g4lB-4y9sA:23.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223MET A 336ASP A 370PRO A 374TRP A 384THR A 385PHE A 424 | None4QJ A 603 ( 4.9A)4QJ A 603 ( 3.9A) ZN A 601 (-2.5A)NoneNoneNone4QJ A 603 (-3.5A) | 0.48A | 3g4lB-5b25A:43.6 | 3g4lB-5b25A:37.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 6 | TYR A 668HIS A 669MET A 785ASP A 823TRP A 837PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.0A) ZN A1001 (-2.6A)NoneLLN A1003 (-3.8A) | 0.43A | 3g4lB-5h2rA:38.9 | 3g4lB-5h2rA:31.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mov | CASEIN KINASE IISUBUNIT ALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHC4 A 401 ( 3.7A)HC4 A 401 ( 4.0A)HC4 A 401 (-3.4A) | 1.41A | 3g4lB-5movA:undetectable | 3g4lB-5movA:23.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519ASP A 564LEU A 565PRO A 568TRP A 578THR A 579ILE A 582MET A 583PHE A 618 | NoneNone9VE A 801 (-3.8A) ZN A 699 ( 2.6A)9VE A 801 (-4.7A)9VE A 801 (-3.9A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 ( 4.0A)9VE A 801 (-3.9A) | 0.26A | 3g4lB-5ohjA:52.0 | 3g4lB-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519LEU A 565PRO A 568TRP A 578THR A 579ILE A 582MET A 583MET A 603PHE A 618 | NoneNone9VE A 801 (-3.8A)9VE A 801 (-4.7A)9VE A 801 (-3.9A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 ( 4.0A)9VE A 801 (-3.6A)9VE A 801 (-3.9A) | 0.52A | 3g4lB-5ohjA:52.0 | 3g4lB-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oj3 | - (-) |
no annotation | 5 | ASP A 251LEU A 254PRO A 305THR A 295PHE A 292 | None | 1.31A | 3g4lB-5oj3A:undetectable | 3g4lB-5oj3A:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 6 | HIS A 83MET A 195ASP A 236LEU A 237PRO A 240PHE A 291 | NoneNone ZN A 401 (-2.4A)NoneNoneNone | 0.51A | 3g4lB-5vydA:39.8 | 3g4lB-5vydA:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 6 | HIS A 83MET A 195ASP A 236LEU A 237TRP A 250PHE A 291 | NoneNone ZN A 401 (-2.4A)NoneNoneNone | 0.61A | 3g4lB-5vydA:39.8 | 3g4lB-5vydA:30.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TRP A 332THR A 333ILE A 336MET A 337MET A 357PHE A 372 | AKJ A 601 ( 4.7A)NoneAKJ A 601 ( 3.9A) ZN A 602 (-2.5A)AKJ A 601 ( 4.6A)AKJ A 601 (-3.9A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 ( 3.7A)AKJ A 601 (-3.4A)AKJ A 601 (-4.1A) | 0.43A | 3g4lB-5wh6A:54.0 | 3g4lB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xvu | CASEIN KINASE 2,ALPHA SUBUNIT (Plasmodiumfalciparum) |
PF00069(Pkinase) | 5 | HIS A 158LEU A 89ILE A 178MET A 167PHE A 117 | NoneNoneATP A 403 ( 4.5A)ATP A 403 ( 3.7A)None | 1.48A | 3g4lB-5xvuA:undetectable | 3g4lB-5xvuA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z9x | SMALL RNA DEGRADINGNUCLEASE 1 (Arabidopsisthaliana) |
no annotation | 5 | HIS A 236LEU A 85THR A 138ILE A 219MET A 140 | None | 1.31A | 3g4lB-5z9xA:undetectable | 3g4lB-5z9xA:undetectable |